Previous Article | Next Article 
Journal of Virology, May 2000, p. 4483-4494, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Posttranscriptional Inhibition of Class I Major
Histocompatibility Complex Presentation on Hepatocytes and Lymphoid
Cells in Chronic Woodchuck Hepatitis Virus Infection
Tomasz I.
Michalak,1,2,*
Paul D.
Hodgson,1 and
Norma D.
Churchill1
Molecular Virology and Hepatology Research,
Division of Basic Medical Sciences,1 and
Division of Pathology,2 Faculty of
Medicine, Health Sciences Centre, Memorial University of
Newfoundland, St. John's, Newfoundland A1B 3V6, Canada
Received 15 November 1999/Accepted 17 February 2000
 |
ABSTRACT |
Woodchuck hepatitis virus (WHV), similar to human hepatitis B
virus, causes acute liver inflammation that can progress to chronic
hepatitis and hepatocellular carcinoma. WHV also invades cells of the
host lymphatic system, where it persists for life. We report here that
acute and chronic hepadnavirus hepatitis is characterized by a profound
difference in the expression of class I major histocompatibility
complex (MHC) molecules on the surface of infected hepatocytes and,
notably, lymphoid cells. While acute WHV infection is accompanied by
the enhanced hepatocyte surface presentation of class I MHC antigen and
upregulated transcription of the relevant hepatic genes, inhibition of
class I antigen display on liver cells is a uniform hallmark of chronic
WHV infection. This inhibition in chronic hepatitis occurs despite
augmented (as in acute infection) expression of hepatic genes for class I MHC heavy chain,
2-microglobulin, and transporters
associated with antigen processing (TAP1 and TAP2). Further, the class
I antigen inhibition is not related to the histological severity of
hepatocellular injury, the extent of lymphocytic infiltrations, the
level of intrahepatic gamma interferon induction, or the hepatic WHV
load. Importantly, the antigen expression is also inhibited on organ
lymphoid cells of chronically infected hosts. The results obtained in
this study demonstrate that the defective presentation of class I MHC
molecules on cells supporting persistent WHV replication is due to
viral posttranscriptional interference. This event may diminish the
susceptibility of infected hepatocytes to virus-specific T-cell-mediated elimination, hinder virus clearance, and deregulate the
class I MHC-dependent functions of the host immune system. This
multifarious effect could be critical for perpetuation of liver damage
and evasion of the antiviral immunological surveillance in chronic
infection and therefore could be supportive of hepadnavirus persistence.
 |
INTRODUCTION |
The hepatitis B virus (HBV) is a
small, noncytopathic DNA virus, the prototype of the hepadnavirus
family. This virus causes acute and chronic liver inflammation and
hepatocellular carcinoma in humans. The host cellular immune responses
directed against HBV peptides displayed on infected hepatocytes,
particularly those mediated by cytotoxic T lymphocytes (CTL), are
considered to be crucial in the induction of hepatic damage and
probably contribute to both cytopathic and noncytopathic elimination of
the virus from infected livers (5, 18). A strong CTL
response specific to multiple HBV epitopes has been identified during
and years after recovery from acute hepatitis (AH) (39, 42,
44). Conversely, CTL specific for HBV have been found
infrequently in peripheral blood and at low precursor levels in livers
in patients with chronic hepatitis (CH) (2, 12), even though
sustained liver cell damage coexists with intrahepatic
lymphomononuclear infiltrations and high virus loads in many
chronically infected patients. Although a diminished antiviral CTL
response is thought to be the main contributor to the pathogenesis of
CH type B, the basis of this hindrance remains uncertain. Since
triggering and the strength of antiviral CTL responsiveness depend to a
significant degree on the efficient cell surface presentation of viral
peptides by class I major histocompatibility complexes (MHC),
delineation of the changes and the mechanism(s) modulating their
expression in the course of viral hepatitis might be decisive for
understanding the pathogenesis of protracted liver disease and virus
persistence in hepadnavirus infection. The above reasoning has proven
to be correct for other viruses. These investigations have shown that virus-induced alterations in the class I MHC surface display play an
important role in viral pathogenesis and persistence (13, 37, 40,
45).
Lymphotropism is a common feature of many viruses capable of induction
of long-term infection in the host. It is now evident that although the
liver is the main site of HBV replication and hepatic tissue injury is
a leading source of clinical manifestations, the virus also infects the
host lymphatic system. Different forms of HBV DNA, including the
covalently closed circular DNA and replicative intermediates, as well
as viral transcripts, have been identified in lymphoid cells (reviewed
in references 29 and 30). The direct link between HBV lymphotropism and chronic infection is not yet
established. However, it is conceivable that, as in other viral
infections, invasion of the lymphatic system may have a detrimental
effect on a variety of the host immune responses. Among others, the
virus may alter the display of class I MHC molecules on lymphoid cells
and, in consequence, impair a variety of cell immune functions.
The woodchuck (Marmota monax) is a natural model of
hepadnavirus hepatitis that reflects, with a high degree of accuracy, virological and pathobiological events occurring in HBV-infected patients (29, 50). Similar to HBV, woodchuck hepatitis virus (WHV) induces acute infection that can progress to CH and
hepatocellular carcinoma. In this study, we investigated the
WHV-woodchuck model to elucidate the relationship between the acute and
chronic phases of hepadnavirus infection and the class I MHC
presentation on cells naturally supporting WHV replication. We have
also searched for a molecular basis of the discovered disparities in
class I MHC expression. In contrast to past evaluations, which reached conflicting conclusions based on immunohistochemical stainings of liver
tissue from HBV-infected patients (6, 26, 43), purified cell
plasma membranes, quantitative and highly sensitive immunoblotting
techniques, and molecular methods measuring class I MHC-affiliated gene
activity were used in this study. We report that acute and chronic WHV
infections are characterized by a profound difference in presentation
of class I antigen on hepatocytes and organ lymphoid cells. Hence,
while AH is accompanied by an augmented expression of class I molecules
on liver cells but an unaltered display on lymphoid cells, inhibition
of the antigen presentation on both cell types is a uniform
characteristic of chronic WHV infection. Interestingly, this inhibition
in CH occurs despite upregulated transcription of the hepatic genes
encoding class I MHC heavy (
) and light
(
2-microglobulin) chains and transporters associated
with antigen presentation (TAP1 and TAP2), implying that the defect in
class I molecule presentation occurs posttranscriptionally.
 |
MATERIALS AND METHODS |
Animals and categories of WHV infection.
Fourteen woodchucks
constituted the main study group (study group 1). In this group, eight
animals (WM 2070, WF 2112, WF 2114, WF 2131, WM 2121, WF 2160, WM 2167, and WM 2171) were infected intravenously with WHV (33, 35).
Four others (WF 2020, WF 2030, WM 2040, and WM 2150) had naturally
acquired, WHV surface antigen (WHsAg)-positive CH, which was monitored
for up to 21 months prior to the start of the experiment. Two healthy
animals (WM 2075 and WF 2078) were examined as controls (Table
1). All the woodchucks except WF 2112 and
WM 2121 were a part of our previous study aimed at identification of
molecular species of WHV structural proteins and the nature of their
interactions with hepatocyte plasma membranes (HPM) in AH and CH and in
recovery (33).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Immunovirological and histological characteristics of WHV
infection in animals studied at the time of analysis of class I
MHC expression
|
|
The serological status of WHV infection was determined by testing
sequentially collected sera for WHsAg, antibodies to WHsAg
(anti-WHs),
and antibodies to WHV core antigen (anti-WHc) by immunoassays
as
described previously (
9,
33,
35). The serum WHV DNA
level
was determined by slot blot hybridization (
35) and, when
negative, by PCR using WHV core gene specific primers, as described
previously (
7,
35).
Histological examination of liver samples, obtained by laparotomy 3 to
4 weeks prior to the experiment or at the time of liver
perfusion, was
done after conventional processing to paraffin.
Paraffin sections (4 µm) were stained with hematoxylin and eosin,
Masson-trichrome, or
periodic acid-Schiff or impregnated with
silver (
33). The
morphologic assessment of liver damage, referred
to as the histological
degree of hepatitis, was based on criteria
described in our previous
works (
33,
34).
Based on serological and histological assessments, woodchucks in study
group 1 were classified into three categories: (i)
healthy or recovered
from AH (
n = 4), (ii) with AH (
n = 4),
and
(iii) persistently infected, with serologically and histologically
evident CH (
n = 6) (Table
1). Histological examination
showed
a highly variable degree of inflammatory liver injury in the
animals
examined (Table
1). The changes ranged from minor lesions
(grade
I; WM 2070 and WF 2114) through mild AH or CH (grade II; WF
2030,
WM 2040, and WM 2167) to severe liver injury with heavy
lymphocytic
infiltrations and prominent necrosis of parenchyma (grade
III;
WF 2020, WF 2112, WM 2121, WM 2150, and WM 2171). Liver biopsy
specimens from healthy animals (WM 2075 and WF 2078) did not show
morphological alterations, whereas hepatic changes in woodchucks
which
had recovered from AH (WF 2131 and WF 2160) were minimal
and consisted
mainly of minor lymphomononuclear infiltrations
in some portal areas
and scanty intralobular infiltrations surrounding
singular degenerating
hepatocytes, as reported previously (
35).
Liver and spleen specimens from seven other woodchucks with detailed
characterization of serological and histological profiles
of AH
(
n = 3) or CH (
n = 4) and from two
healthy animals (study
group 2) were also investigated (Table
1).
Hepatic histological
lesions in this group varied from none in healthy
animals (WM
3069 and WF 3299) through minor (grade I; WF 3392 and WF
4832)
and moderate (grade II; WF 3349, WF 3838, and WF 4980) to severe
(grade III; WM 3158 and WF 4751) in animals with either AH or
CH. In
addition, several other woodchucks with a well-defined
status of WHV
infection were used as a source of peripheral blood
mononuclear cells
(PBMC) to test the class I MHC display on the
surface of circulating
lymphoid cells. For this purpose, freshly
isolated PBMC from two
animals with AH, two animals convalescent
from AH, four animals with
CH, and four healthy animals were examined
by flow cytometry (see
below). In a parallel experiment, PBMC
collected from two woodchucks
prior to WHV infection and then
during AH and from two other animals
before WHV administration,
during AH, and then during advanced CH were
used for isolation
of PBMC plasma membranes and evaluation of class I
MHC heavy-chain
presentation by
immunoblotting.
Cells and plasma membranes.
Hepatocytes were isolated by
two-step collagenase perfusion of livers from animals in study group 1 using methods reported previously (31, 33, 36). HPM were
purified from the isolated hepatocytes by differential fractionation in
sucrose gradients (31). The purity of HPM was determined by
measuring the activities of marker enzymes for plasma membranes
(5'-nucleotidase), microsomes (glucose-6-phosphatase), and mitochondria
(cytochrome c oxidase) (31, 33). These
evaluations showed that the HPM were essentially free from subcellular
contamination and of comparable purity. Kidney plasma membranes (KPM)
were isolated from the woodchuck kidney homogenates by using the HPM
isolation procedure.
Splenic lymphomononuclear cells (splenocytes), containing mainly
lymphocytes, were prepared by two sequential density gradient
centrifugations in Histopaque 1119 (Sigma Chemical Co., St. Louis,
Mo.)
as described previously (
32). After depletion of residual
erythrocytes, spleen plasma membranes (SPM) were purified by hypotonic
treatment and sucrose gradient centrifugation (
32).
PBMC were isolated from freshly drawn blood treated with EDTA by a
gradient centrifugation in Histopaque (
22,
32). Plasma
membranes were prepared by hypotonic shock, brief sonication,
and
subsequent removal of nuclei and cellular debris by centrifugation,
as
described previously (
23). The protein content was
determined
by a bicinchoninic acid protein assay
(Sigma).
MAb to woodchuck class I MHC heavy chain.
Mouse monoclonal
antibody (B1b.B9 MAb) against a nonpolymorphic epitope of the woodchuck
class I MHC heavy chain was generated and characterized in our previous
study (32). This antibody recognizes two polypeptide species
of woodchuck class I heavy chains with molecular masses of 43 and 39 kDa.
Dot and Western immunoblotting.
Plasma membranes,
subcellular fractions, or tissue homogenates were immobilized at the
desired protein concentration onto nitrocellulose (pore size, 0.45 µm; Bio-Rad Laboratories, Richmond, Calif.); exposed to a blocking
solution containing 3% bovine serum albumin, 1% normal goat serum,
0.05% Tween 20, and 0.001% sodium azide in phosphate-buffered saline
(pH 7.4) (PBS); and incubated with B1b.B9 MAb under conditions
described previously (32). After incubation and washing, the
blots were exposed to goat anti-mouse antibody conjugated with alkaline
phosphatase (Jackson ImmunoResearch Laboratories Inc., West Grove, Pa.)
and washed, and the reactions were developed (9).
For Western immunoblotting, purified membrane preparations were
subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) at 20 µg of protein/lane and separated proteins were
electrotransferred onto nitrocellulose and immunoblotted as described
previously (
9,
33). The efficiency of protein transfer and
the molecular masses of the detected polypeptide species were
determined using prestained molecular weight markers (Bio-Rad
Laboratories). The relative expression of class I MHC heavy and
light
chains was determined by densitometry using a computerized
Chemi-Imager
4000 System (Canberra-Packard Canada Ltd., Mississauga,
Ontario,
Canada).
Immunohistochemical staining.
Cryostat sections 4 µm thick
were cut from frozen liver and spleen tissue blocks, air dried, and
fixed in cold acetone-chloroform (1:1) mixture for 5 min at ambient
temperature (32). The sections were hydrated in PBS,
incubated for 45 min with B1b.B9 MAb or PBS (control), and washed for
30 min in three changes of PBS. Subsequently, sections were incubated
with fluorescein isothiocyanate (FITC)-conjugated anti-mouse
immunoglobulin G (IgG) (H+L) antibody (Jackson ImmunoResearch
Laboratories Inc.) for 30 min, washed three times for 10 min each in
PBS, mounted in 20% glycerol buffered in PBS, and examined using a
Leitz-Diaplan epifluorescence microscope.
Flow cytometry.
Freshly isolated PBMC, approximately 5 × 105 cells/sample with viability greater than 95% by
trypan blue exclusion, were incubated with B1b.B9 MAb or PBS (control)
and then with anti-mouse antibody labeled with FITC (Jackson
ImmunoResearch Laboratories Inc.) by a procedure described previously
(32). Cell analysis was done using a FACS Star-Plus flow
cytometer (Becton-Dickinson, Mississauga, Ontario, Canada).
DNA and RNA extractions.
DNA was isolated by proteinase K
digestion, phenol-chloroform extraction, and precipitation with ethanol
by standard methods (49). Total RNA was extracted from
mechanically pulverized frozen tissue using TRIzol reagent (Gibco BRL,
Grand Island, N.Y.). Nucleic acids were quantitated by standard
spectroscopic analysis and stored in small aliquots at
80°C prior
to use.
Dot blot detection of tissue WHV DNA.
For WHV DNA
hybridization, 5 µg of liver or 10 µg of spleen DNA was denatured
by boiling for 10 min in 200 µl of 6× SSC (pH 7.0) (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate), chilled on ice, and immobilized on
a nylon membrane (Hybond-N; Amersham Life Sciences, Arlington Heights,
Ill.) using a BioDot SF apparatus (Bio-Rad Laboratories). The membrane
was hybridized for 16 h at 65°C to a full-length, linearized,
cloned WHV DNA (41) labeled with [32P]dCTP by
a random primer method (Rediprime; Amersham Life Sciences). The blot
was washed to final stringency of 0.2× SSC-0.1% SDS for 30 min at
65°C and exposed to X-ray film (XRP-1 or XAR-5; Eastman Kodak Co.,
Rochester, N.Y.) with an intensifying screen or to a phosphor screen
(Canberra-Packard Canada Ltd.). For estimation of the levels of WHV DNA
expression, autoradiographic or phosphor images of hybridization
signals were quantitated for equivalence with 10-fold serial dilutions
of recombinant, complete WHV DNA using a chemi-image analyzer or a
Cyclone phosphorimaging system (Canberra-Packard Canada Ltd.), respectively.
Cloning of woodchuck class I MHC heavy chain,
2-microglobulin, TAP1, TAP2, CD3 and IFN-
.
Total
RNA isolated from the spleen of a healthy woodchuck was reverse
transcribed to cDNA as described previously (35). The
resulting cDNA was amplified by PCR with oligonucleotide primers which
were deduced through interspecies comparison of human, mouse, rat, and
rabbit (when available) mRNA sequences using PC Gene software
(IntelliGenetics Inc., Mountain View, Calif.). For amplification of the
woodchuck class I MHC heavy-chain sequence, sense primer MHC-W
(5'-AGTCTTTCCGAGTGAACCTGCGGAC) and antisense primer W-CHM (5'-TCCTTTCCCATCTGAGCTGTGCTTC) were used. The woodchuck
2-microglobulin was amplified with the sense and
antisense degenerative primers
2M-plus (5'-ATGKCTCGCTCSGTGRCC)
and
2M-minus (5'-TTACATGTCTCGRTCCCAS), respectively. The
woodchuck TAP1 sequence was amplified with sense primer APT-1
(5'-TTCTTYACRGGCCGCMTCACTGAC) and antisense primer 1-PAT
(5'-AGGGCACTGGTGGCATCRTC), whereas the TAP2 sequence was amplified
with sense primer APT-2 (5'-TTCGGGTCGTGTRATTGACATCC) and antisense
primer 2-PAT (5'-CTTSACAGAACCSGAGAACAGCAC). For identification of the
woodchuck CD3 gene, whose transcripts are specific for T lymphocytes,
primers CD3P (5'-CTGGGACTCTGCCTCTTATC) and CD3M
(5'-GCTGGCCTTTCCGGATGGGCTC), with sequences essentially identical to those reported by others (38), were used.
Woodchuck gamma interferon (IFN-
) was amplified with primers
designed in this laboratory, W-IFNG (5'-GGCCTAACTCTCTCTGAAACG)
and W-GNFI (5'-GAGGACTGTTATTTGGATGC). In addition, an
approximately 315-bp fragment of woodchuck
-actin and a 570-bp
fragment of glyceraldehyde-3-phosphate dehydrogenase (GADPH) were
generated by PCR using woodchuck liver cDNA and oligonucleotide primers
published previously for human
-actin (16) and mouse
GADPH (24). For PCR amplification of cDNA to be cloned,
samples were denatured at 94°C for 5 min, followed by 35 cycles of
94°C for 1 min, 52°C for 2 min, and 72°C for 3 min. The last
cycle was followed by an elongation step at 72°C for 10 min. PCR
amplifications were carried out in a TwinBlock thermal cycler (Ericomp
Inc., San Diego, Calif.) using 5 µl of the reverse transcription
reaction product and a standard reagent mixture described previously
(35). The specificity of the amplified woodchuck DNA
fragments was verified by Southern blot analysis using internal
oligonucleotide probes, except for the class I MHC heavy chain, which
was probed with a 32P-labeled fragment of rabbit class I
MHC (exon 4) excised from plasmid pUC12-RLA-A (ATCC 77230)
(28). After confirmation of specificity, the DNA amplicons
were purified from low-melting-point agarose using the Wizard PCR Preps
DNA purification system (Promega Corp.) and cloned into vector pCRII
using a TA cloning kit (Invitrogen, Carlsbad, Calif.). After plasmid
amplification, the specificity and orientation of the fragments cloned
were validated by sequencing by using either the fmol DNA
sequencing system (Promega Corp.) or a fluorescence-based automated
sequence analyzer (LI-COR; LiCor Inc., Lincoln, Neb.).
Analysis for class I MHC-affiliated RNAs.
Liver RNA was
analyzed for class I MHC heavy chain,
2-microglobulin,
TAP1, and TAP2, as well as for CD3, WHV,
-actin, and GADPH
expression, by Northern blot hybridization. Transcription of the above
genes was also assessed in the spleens of the animals examined.
Briefly, 10 or 20 µg of total liver or spleen RNA was separated
electrophoretically using a standard formaldehyde-denaturing-agarose method (3), blotted onto a nylon membrane (Hybond-XL;
Amersham Life Sciences) by download capillary transfer, and baked for
2 h at 80°C. The blots were hybridized for 18 h at 42°C
to probes excised from relevant clones by EcoRI digestion
and labeled with 32P using the Strip-EZ DNA kit (Ambion
Inc., Austin, Tex.). After hybridization, the membranes were washed to
a final stringency of 0.2× SSC-0.1% SDS at 42°C and exposed for
autoradiography or phosphorimager analysis. Prior to rehybridization,
probes were stripped from the membranes as specified by the
manufacturer of the Strip-EZ DNA kit. The signal intensity was
quantified and equalized to
-actin expression by densitometry.
Intrahepatic IFN-

RNA expression was estimated by relative PCR using
woodchuck liver cDNAs and oligonucleotide primers listed
above. PCR was
performed in the linear amplification range under
the following
conditions: 94°C for 5 min, 51°C for 2 min, and
72°C for 1 min in
the first cycle; then 94°C for 1 min, 52°C for
1.5 min, and 72°C
for 1.5 min for 34 cycles; and a final extension
at 72°C for 10 min.
As loading controls, the same cDNA samples
were amplified with

-actin primers. The resulting PCR products
were analyzed by Southern
blot hybridization with appropriate
cloned probes and compared to

-actin expression with a phosphorimager
analyzer.
Nucleotide sequences accession numbers.
The accession
numbers for the woodchuck nucleotide sequences derived in this study
submitted to GenBank were as follows: class I MHC heavy chain,
AF232723; TAP1, AF232724; TAP2, AF232725;
2-microglobulin, AF232726; CD3, AF232727; IFN-
,
AF232728; GADPH, AF232729; and
-actin, AF232730.
 |
RESULTS |
Upregulated expression of class I MHC on the hepatocyte surface is
a hallmark of acute but not chronic WHV infection.
Liver sections
from healthy and convalescent animals showed immunofluorescent staining
of sinusoidal lining cells and the bile duct epithelia but little or no
expression of class I MHC heavy chain at hepatocyte outer membranes
(Fig. 1A). In the livers of animals with
AH, a strong staining of periportal and intralobular inflammatory
infiltrates and membranes of the hepatocytes adjacent to these
infiltrates were seen. The lobular hepatocytes, not associated with
inflammatory cells, showed a membranous staining of part or the entire
surface, while their cytoplasm essentially remained negative (Fig. 1B).
Woodchucks chronically infected with WHV had an enhanced display of the
class I antigen on hepatocytes only in the areas of inflammatory
infiltrations. Hepatocytes distant from the infiltrates were
nonreactive (Fig. 1C); however, some cells, usually occurring in
clusters, had weak staining at their outer membranes. Overall, the
class I MHC pattern was noticeably different in AH and CH, but there
was no relation between this display and the overall histological
severity of liver injury. There also was no differences in the MHC
antigen staining on sinusoidal lining endothelium or on the bile duct
epithelium in livers from infected, healthy, or recovered animals.
Sections incubated with the second layer antibody alone showed the same
minimal background staining in all livers examined.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 1.
Immunofluorescent identification of the class I MHC
expression in livers of healthy and WHV-infected woodchucks. Cryostat
sections from hepatic tissue of a normal woodchuck (WM 2075) (A) and
livers of animals with AH (WM 2121) (B) and CH (WF 2114) (C) were
incubated with B1b.B9 MAb directed against woodchuck class I MHC heavy
chain followed by FITC-labeled anti-mouse IgG. A plasma
membrane-associated pattern of the class I MHC staining of intralobular
hepatocytes is evident in the liver of the animal with AH but not in
the livers of the healthy woodchuck and that with CH. Magnification,
×400.
|
|
All HPM preparations isolated from study group 1 and probed with B1b.B9
MAb by Western blotting demonstrated the class I heavy-chain
43-kDa
polypeptide, although the protein was displayed at markedly
higher
density in HPM from animals with AH (Table
2 and Fig.
2). The HPM from healthy and convalescent
woodchucks, as well
as those from animals with CH, showed noticeably
lower expression
of the polypeptide. In addition to the 43-kDa species,
the 39-kDa
polypeptide was detected on hepatocyte outer membranes from
animals
with AH (Fig.
2 and Table
2). This band was not identifiable
on
blots of the membranes from healthy, recovered, or chronically
infected
woodchucks. The detection of the 39-kDa polypeptide was
consistent with
our previous finding that only woodchuck cells
displaying surface class
I MHC molecules at the highest densities
(e.g., normal splenic lymphoid
cells) show both 43- and 39-kDa
heavy-chain species (
32).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Hepatocyte surface membrane expression of class I MHC
heavy chain in woodchucks with WHV hepatitis and in control animals
|
|

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of the class I MHC heavy chain on HPM in
animals with AH and CH, healthy woodchucks, and an animal convalescent
from self-limiting AH (SLAH). Purified hepatocyte outer membranes were
separated at 20 µg of protein/lane on SDS-PAGE (12% polyacrylamide
gel), electrotransferred onto nitrocellulose, and probed by Western
blotting with B1b.B9 MAb against woodchuck class I MHC heavy chain. The
positions of the class I 43- and 39-kDa heavy-chain polypeptides and
the prestained protein standards (lane 1) are indicated on the right
and left side, respectively. The relative density values of the
identified heavy-chain protein bands (scale from 0 to 4) were assigned
based on integrated chemi-image scanning values. The heavy-chain
display is augmented in HPM from animals with AH, whereas HPM from
woodchucks with CH, as well as those from healthy or recovered animals,
have comparably very low contents.
|
|
Densitometric quantitation of the class I heavy-chain signals detected
by Western (Fig.
2 and Table
2) or immunodot (Table
3) blotting confirmed a significant
difference in the hepatocyte
surface presentation of class I MHC
between acutely infected and
healthy, recovered, or chronically
infected animals. Thus, HPM
from either healthy or convalescent
woodchucks, which had normal
(WM 2075 and WF 2078) or nearly normal (WF
2131 and WF 2160) liver
histology, displayed approximately the same
amounts of class I
heavy chain. In contrast, the quantity of MHC on HPM
from AH was
on average 3.5-fold greater than that on the membranes from
healthy
and convalescent woodchucks (Table
3). When HPM from animals
with AH and CH were compared, a 3.2-fold-lower content of the
heavy
chain was found on the membranes derived from chronically
infected
animals (Table
3). Taken together, the hepatocyte surface
expression of
class I MHC was evidently elevated in woodchucks
with AH but was
essentially the same in woodchucks with CH and
in the healthy or
convalescent woodchucks.
It is of note that probing of the whole-liver homogenates with B1b.B9
MAb by immunodot and Western blotting did not show detectable
variation
in the hepatic class I MHC content between infected
and healthy
animals. This observation supported the conclusion
that the identified
difference was restricted predominantly to
the hepatocyte surface.
There was no variation in the class I
heavy-chain display on KPM
purified from the animals examined
(Table
3).
Inhibition of hepatocyte surface class I MHC expression is
associated with chronic WHV infection but not with hepatic virus load,
severity of hepatitis, or intrahepatic level of IFN-
induction.
The level of the class I heavy-chain expression on HPM was not related
to the amount of WHV present in the liver. The average hepatic content
of WHV DNA was 6.1 × 107 ± 1.2 × 107 (standard error of the mean) virus genome equivalents
(vge)/µg of liver DNA in acutely infected animals and 8.2 × 107 ± 4.5 × 107 vge/µg in animals
with CH. Also, the hepatic expression of WHV-specific mRNA, determined
by Northern hybridization and densitometric analysis, was not
meaningfully different between woodchucks with AH and CH (see Fig. 6).
In animals which had recovered from AH (WF 2131 and WF 2160), traces of
WHV genome were identifiable in the livers by nested PCR followed by
Southern hybridization of the amplified products (sensitivity,
<102 WHV vge/ml). This result corroborates our previous
findings which demonstrated that traces of replicating WHV persist in
the liver for life after resolution of AH (35). In these
serologically silently infected animals, hepatocyte membrane expression
of class I antigen was not appreciably different from that in healthy
woodchucks. Collectively, these data showed that comparable hepatic
loads of WHV were accompanied by strikingly distinct hepatocyte surface display of class I MHC molecules that depended on whether HPM originated from acutely or chronically infected animals.
As illustrated in Fig.
2 and Table
2, there was also no correlation
between the hepatocyte surface presentation of class
I molecules and
the histological severity of liver disease. Albeit,
HPM from animals
with the most severe AH (WM 2121 and WM 2171)
tended to display larger
amounts of class I heavy chain than did
HPM from woodchucks with mild
or moderate AH (WM 2070 and WM 2167).
HPM from animals with chronic
infection, which had histologically
very mild (WF 2114), moderate (WF
2030 and WM 2040), or severe
(WF 2020, WF 2112, and WM 2150) hepatitis,
showed comparably low
levels of surface class I heavy chain. The
intrahepatic CD3 RNA,
an indicator of T-lymphocyte infiltrations, was
barely detectable
in healthy animals but was elevated to the same level
in woodchucks
with AH and CH (see Fig.
6). Similarly, the levels of
IFN-

RNA
in the liver were comparable in acutely and chronically
infected
woodchucks but were on average approximately 4.5-fold greater
than those in healthy animals (Fig.
3).
Overall, these data pointed
out that the status of the class I MHC
expression on hepatocyte
surface in actively progressing hepatitis was
not related to the
histological severity of hepatocellular injury, the
degree of
lymphocytic infiltrations, or the intrahepatic IFN-

activity
but was clearly connected with chronicity of WHV infection.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 3.
Expression of IFN- mRNA in livers of woodchucks with
AH or CH. Total liver RNA was reverse transcribed to cDNA and amplified
with woodchuck IFN- - and -actin-specific primers, as described in
Materials and Methods. The amplified PCR products were detected by
Southern blot hybridization. The signals showed that the hepatic levels
of IFN- induction are comparable in animals with AH and CH.
|
|
Chronic but not acute WHV infection is associated with
downregulation of class I MHC antigen expression in lymphoid
cells.
Because WHV replicates in both hepatocytes and lymphoid
cells, it was of interest to establish whether the class I antigen display differs in the lymphatic tissue in AH and CH.
Immunohistochemical staining of spleen sections from healthy and
WHV-infected animals showed the same intensity of class I MHC
expression on the cells lining splenic sinuses and blood vessels. The
staining of the periarteriolar lymphoid sheaths, which are enriched in
lymphoid cells, also was similar in healthy (Fig.
4A), recovered (data not shown), and
acutely infected (Fig. 4B) woodchucks. However, lymphoid cells in the
same periarteriolar regions in animals with CH showed recognizably less
intense and sometimes almost absent staining for the class I heavy
chain, even though the endothelial cells remained positive (Fig. 4C).

View larger version (85K):
[in this window]
[in a new window]
|
FIG. 4.
Splenic distribution of class I MHC in healthy and
WHV-infected woodchucks. (A and B) Sections from spleens of a healthy
animal (WM 2075) (A) and from a woodchuck with AH (WM 2167) (B)
incubated with B1b.B9 MAb and FITC-labeled anti-mouse IgG show
immunofluorescent staining of lymphocytes as well as endothelium lining
intrafollicular capillaries (arrowheads) and the central arteriole
(arrow). (C) The same staining of a spleen section from a woodchuck
with CH (WM 2150) demonstrates class I MHC expression on endothelium of
blood capillaries (arrowheads) but not on lymphoid cells.
Magnification, ×400.
|
|
Western blotting of SPM isolated from WHV-infected, recovered, or
healthy woodchucks showed both 43- and 39-kDa heavy-chain
polypeptide
bands. The same protein bands, or in some cases only
the 43-kDa
species, were exhibited at lower densities in SPM from
animals with CH
(data not shown). Determination of the class I
heavy-chain display by
immunodot blotting and subsequent densitometric
analysis revealed
closely comparable levels of class I heavy chain
in SPM from healthy,
convalescent, and acutely infected animals,
similar to the results of
Western blot analyses (Table
3). In
contrast, the class I heavy-chain
content was evidently reduced
in SPM from woodchucks with CH. Overall,
SPM from chronically
infected animals displayed more than a
20-fold-lower level of
class I MHC than did SPM from woodchucks with AH
or healthy controls
(Table
3). Interestingly, identical results were
obtained when
the whole-spleen homogenates, instead of SPM, were probed
with
B1b.B9 MAb, as illustrated in Fig.
5. This finding suggested that
class I
MHC expression in chronic infection is not confined to
the lymphoid
cell surface, as seems to be the case in WHV-infected
hepatocytes, but,
rather, has a pancellular character. In contrast
to splenic tissue,
immunodot blots of KPM preparations (Table
3), as well as whole-kidney
homogenates from the same animals
(data not shown), did not show any
variation in the class I MHC
heavy-chain content.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 5.
Expression of class I MHC heavy chain in spleens of
woodchucks with AH or CH and from control animals. Serial twofold
dilutions of whole-spleen homogenates prepared from woodchucks with AH
or CH, healthy animals, and a woodchuck convalescent from self-limited
AH (SLAH) were immobilized onto nitrocellulose at the indicated protein
concentrations and probed with woodchuck class I heavy-chain-specific
B1b.B9 MAb. The heavy-chain expression is faint in splenic tissue from
animals with CH but is intense and not altered in animals with AH and
in convalescent or healthy animals.
|
|
The WHV genome levels in the spleens of animals with AH and CH were
comparable, with an average viral DNA content of 8.4 ×
10
5 ± 3.4 × 10
5 vge/µg of splenic
DNA for animals with AH and 1.9 × 10
6 ± 1.1 × 10
6 vge/µg for woodchucks with CH, while WHV
mRNA was not detectable
by Northern blotting. Renal tissue was WHV DNA
and mRNA nonreactive
by the same assays in the animals
examined.
In separate experiments, the density of the class I MHC heavy-chain
expression on intact, freshly isolated PBMC and on purified
PBMC
surface membranes was determined. Analysis of comparable
numbers of
PBMC by flow cytometry and the same amounts of PBMC
membrane proteins
by immunodot blotting with B1b.B9 MAb failed
to demonstrate any
consistent difference between healthy animals
and those with AH or CH
(data not shown). PBMC membranes probed
for class I heavy chain by
Western blotting displayed the 43-kDa
protein only (data not
shown).
Both acute and chronic WHV infection upregulates class I MHC-linked
gene transcription in hepatic but not in splenic tissue.
To
determine whether the detected variation in the cell surface
presentation of class I MHC molecules between AH and CH reflects a
difference in the transcriptional activity of the relevant gene loci,
RNA from the livers and spleens of the animals investigated was probed
for class I MHC heavy and light chains and TAP1 and TAP2 transcripts.
In addition, to learn about possible differences in the T-lymphocyte
contents, RNA preparations from livers and spleens of animals belonging
to study group 2 were analyzed for expression of CD3 gene transcripts.
Northern blot hybridization of hepatic RNA showed markedly elevated
levels of heavy-chain mRNA in both acutely and chronically infected
woodchucks compared to those in healthy or convalescent animals (Fig.
6), as well as increased expression of
2-microglobulin, TAP1, and TAP2 mRNA (Fig. 6B).
Quantitation of the hybridization signals, corrected to
-actin gene
expression, revealed a greater than threefold-enhanced intrahepatic
transcription of the class I heavy-chain gene in woodchucks with AH and
a similar increase in animals with CH compared to normal or recovered
woodchucks (Table 3). In general, the hepatic class I MHC-affiliated
genes were upregulated to the same extent in AH and CH, indicating that
this augmentation was not related to the duration of WHV infection.
Also, the intrahepatic levels of the CD3 RNA were the same in animals
with acute and chronic liver disease, revealing that the magnitude of
lymphocytic infiltrations was comparable in these two phases of
WHV-induced necroinflammation in the animals studied (Fig. 6B).
Similarly, as already presented (Fig. 3), the extent of induction of
IFN-
was the same in the livers from acutely and chronically
infected woodchucks. Taken together, these results imply that while
overexpression of class I molecules on hepatocytes in animals with AH
could be explained as a direct consequence of activation of class I MHC genes, the defect in presentation of these molecules in CH was certainly related to posttranscriptional suppression.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 6.
Effect of acute and chronic WHV infection on hepatic
expression of class I MHC-affiliated genes. Total hepatic RNA was
isolated from woodchucks with different histological severity of AH or
CH, an animal convalescent from AH (SLAH), and healthy woodchucks in
study group 1 (A) or 2 (B) (for details, see Table 1). The RNA was
probed by Northern blotting with 32P-labeled woodchuck
class I MHC heavy chain (MHC I h.c.), 2-microglobulin
( 2m), TAP1, TAP2, CD3 cDNA, complete recombinant WHV
DNA, or cloned woodchuck GADPH cDNA and/or human -actin cDNA as
housekeeping genes. Frog liver RNA (A) and human RNA (Hu RNA) (B) were
used as species specificity references. The white asterisk in panel B
depicts a signal that required increased exposure. The expression of
class I MHC heavy and light chains, TAP1, TAP2, and CD3 RNAs is
augmented to the same extent in the livers of both acutely and
chronically infected animals.
|
|
Splenic tissue showed comparable levels of the class I heavy chain,
TAP1, and TAP2 RNAs, as well as CD3 RNA, both in acutely
or chronically
infected woodchucks and in the healthy or recovered
animals (Fig.
7). The exception was
2-microglobulin RNA, which
was moderately elevated in
WHV-infected in comparison to healthy
animals. In addition, the splenic
level of IFN-

RNA was identical
in acute and chronic infection but
at least twice that detected
in healthy controls (Fig.
7). Overall, the
findings showed that
in contrast to the diseased livers, neither acute
nor chronic
WHV infection meaningfully upregulates transcription of the
class
I MHC-linked genes in splenic tissue. These data imply that the
defective expression of class I MHC molecules in splenic lymphocytes
in
chronic WHV infection does not result from inhibited transcription
of
the relevant cellular genes and therefore has to occur at the
posttranscriptional level.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 7.
Relative expression of class I MHC heavy-chain and
related gene mRNA in splenic tissue from woodchucks with acute or
chronic WHV hepatitis. Total RNA isolated from spleens of animals with
AH (n = 3) and CH (n = 4) and from
healthy animals (n = 2) (study group 2) were probed
with 32P-labeled woodchuck class I heavy chain,
2-microglobulin ( 2m), TAP1, TAP2, CD3, or -actin
by Northern blotting, whereas IFN- was assessed by PCR and Southern
blotting as described in Materials and Methods. Hybridization signals
were quantitated by phosphoimager densitometry, normalized to the
-actin, and presented as a percentage of the average amount detected
in the spleens of healthy woodchucks, which were taken as 100%.
|
|
 |
DISCUSSION |
Analysis of hepatocyte surface membranes in this study revealed a
significant difference in hepatocyte presentation of class I MHC
molecules in acute and chronic phases of hepadnavirus hepatitis. While
acute WHV infection is accompanied by increased hepatocyte surface
display of class I MHC, chronic disease, independent of the severity of
liver injury and the duration of chronicity, is uniformly associated
with a decrease in the expression of these molecules similar to that
seen in healthy animals and those convalescent from AH. This defective
class I antigen display in CH occurs in spite of the enhanced
transcription of relevant class I MHC-affiliated hepatic genes, equal
to that observed in the livers of acutely infected hosts. Considering
the above findings, our study demonstrates that hepatocyte presentation
of the class I MHC molecules is evidently enhanced in acute disease but
dramatically suppressed at the posttranscriptional level in chronic
stage of WHV hepatitis. Importantly, this impairment in chronic
infection also affects lymphoid cells, another site of virus
propagation. However, in contrast to the diseased livers, transcription
of the class I MHC-linked genes is not altered in the infected splenic
tissue compared to healthy animals. Also, the splenic display of the
class I MHC molecules is essentially identical in animals with AH and
in the healthy or convalescent woodchucks. In addition, neither acute
nor chronic WHV infection affects the class I MHC antigen expression in
kidneys, which were found to be WHV nonreactive. Collectively, the
present findings show that (i) the liver-restricted, augmented
transcription of the class I MHC-affiliated genes is an invariable
characteristic of any active liver inflammation induced by WHV; (ii)
the severely impaired presentation of class I MHC molecules is a unique
feature of chronic WHV infection; (iii) the decreased cellular
presentation of class I MHC in chronic disease appears to be restricted
to tissues in which WHV actually replicates; and (iv) the deficient hepatocellular and lymphoid cell display of class I MHC in CH is a
consequence of a virus-dependent posttranscriptional inhibition. Overall, the data from our study reveal a transparent although multifarious interplay among phases of hepadnavirus hepatitis, the
status of class I MHC-affiliated gene transcription in virus infected
organs, and the expression of the class I MHC molecules on cells of
these organs.
The class I MHC antigen processing and presentation pathway involves
formation of the trimeric complexes constituted by class I heavy chain,
2-microglobulin, and a proteolytically generated peptide
(19). The assembly of the stable class I MHC molecules requires the translocation of cytosolically produced peptides into the
lumen of the endoplasmic reticulum. This process is facilitated by
transmembrane transporter proteins, referred to as TAP1 and TAP2, which
deliver peptides into the endoplasmic reticulum to bind to empty class
I heavy-chain-light-chain heterodimers (48). The created
trimeric complexes are transported to the cell surface for interaction
with specific CTL. The current model also includes auxiliary molecules,
such as proteasomes, in the generation of peptides for loading onto
class I molecules and emphasizes a role for IFN-
in the modulation
of peptide processing and in upregulation of genes involved in the
antigen class I MHC presentation pathway (reviewed in references
14 and 51).
As uncovered in this study, progressive acute and chronic WHV hepatitis
is accompanied by augmentation of hepatic class I heavy-chain,
light-chain, and TAP genes, as well as by the increased levels of
hepatic T-cell and IFN-
RNAs. Since lymphomononuclear cell
infiltrations are an invariable feature of active liver inflammation in
hepadnavirus infection and since activated T lymphocytes and NK cells,
secreting inflammatory cytokines including IFN-
(17, 47),
are constituents of these infiltrates, induction of intrahepatic IFN-
could be mainly responsible for activation of class I
MHC-affiliated genes in WHV hepatitis. This is supported by the fact
that regulation of class I MHC genes by IFN-
occurs primarily at the
level of gene transcription (52). In addition to the
indirect augmentation through IFN-
, direct upregulation of the class
I MHC genes by viral proteins might be possible. It has been shown in
vitro that the HBV X protein can transactivate the class I MHC
heavy-chain promoter in the virus-transfected HepG2 and related liver
cell lines, leading to a three- to fourfold increase in the heavy-chain RNA and protein levels (53). Since this event has been
observed in the absence of T cells and independently of IFN-
, this
may suggest that the HBV X protein can directly modulate class I MHC gene activity in cultured liver cells. It has also been postulated that
HBV X, by interfering with proteasome functions, may prevent viral
peptide interaction and presentation by class I molecules (21). Determining whether these hypothetical mechanisms
operate in in vivo-infected hepatocytes requires further studies.
In contrast to the livers, the activity of class I MHC genes was not
altered in the spleens of WHV-infected animals, except for that of
2-microglobulin RNA. The divergent effect of WHV infection on the class I MHC gene transcription in the liver and the
spleen could be due to an innate difference in the levels of the gene
expression between these two organs. Quantitative analysis performed in
this study showed that class I heavy-chain mRNA is present at three- to
fourfold-greater levels in the splenic than in the hepatic tissue of
healthy woodchucks. It is possible that while viral infection is
capable of upregulating class I genes in hepatocytes, where their
transcriptional activities are naturally low, it is not able to exert
this additive effect in lymphatic organs like the spleen, where the
gene expression is inherently high. Therefore, WHV infection may act as
a conditional transcriptional inducer whose indirect or direct
modulatory effect depends on the microenvironment regulating the local
activity of class I MHC genes. On the other hand, although perhaps less likely, the lack of class I gene upregulation in the infected spleens
might be a consequence of a 10- to 100-fold-lower WHV DNA and RNA
content than that observed in the livers of these animals. Conceivably,
virus replicating less efficiently or occurring at low levels in
invaded cells might be unable to induce an identifiable increase in
transcription of the class I MHC-linked genes. This situation seems to
be true for livers of woodchucks convalescent from AH, which support
persistent WHV replication at low levels (35) but which do
not show any noticeable change in class I heavy-chain RNA or protein
expression. In addition, the splenic T-cell and IFN-
RNA levels were
identical in acutely and chronically infected animals. Therefore, a
diminished T-cell number or a decrease in the local activity of IFN-
cannot account for the observed class I antigen inhibition in
splenocytes in chronic WHV infection.
The equally augmented expression of hepatic class I MHC-affiliated
genes in AH and CH should imply enhanced synthesis of class I
heterodimers and the availability of processed viral peptides for their
loading. Consequently, this should lead to the increased presentation
of class I complexes on liver cells irrespective of the phase of
hepatitis. However, this situation exists only in acute infection,
where the HPM class I heavy-chain expression was evidently higher than
that detected on HPM from healthy or convalescent animals and appeared
to be proportional to the elevated transcription from the respective
cellular genes. In contrast, the reduced hepatocyte display of class I
heavy chain in chronic infection was accompanied by an increased level
of RNA like that in AH (Table 3). In spleens of chronically infected
animals, unaltered expression of the class I MHC-affiliated genes was
associated with a dramatic (more than 20-fold) reduction in class I
heavy-chain presentation when assessed by immunoblotting. In general,
the results of these quantitative analyses of class I display in
isolated hepatocyte and splenocyte outer membranes agreed with the
results of immunofluorescent staining of tissue sections, but, as
anticipated, they were substantially more sensitive and objective. In
summary, the obtained data clearly document that the disparity between class I-affiliated gene activity and class I antigen display in chronic
infection is not related to downregulation of gene transcription; therefore, it must be due to a virus-dependent posttranscriptional interference that is unique for cells persistently supporting WHV
replication. However, they do not exclude the possibility that the
inhibited presentation of class I molecules can be a consequence of
their impaired trafficking to the cell surface or enhanced recycling.
The observed lack of heavy-chain accumulation in the cytoplasm of the
chronically infected hepatocytes by immunohistochemical staining must
be interpreted with caution, considering the relatively low sensitivity
of this method.
Many viruses inhibit the class I surface molecules on invaded cells to
avoid cytopathic or noncytopathic elimination initiated by specific
CTLs (reviewed in references 13, 37, 40, and 45). It is known that viral proteins may induce
posttranscriptional inhibition of class I antigen by interfering with
the generation or transport of peptides predestined for interaction
with class I heterodimers in the endoplasmic reticulum. They may also
disrupt the class I complex assembly, trafficking, and cell surface
presentation or increase their degradation (reviewed in reference
37). Frequently, the same virus uses a variety of
strategies mediated by more than one viral factor. In the context of
the ability of WHV to suppress class I MHC antigen display in different
cell types, it is conceivable that the virus may also utilize
multifactorial mechanisms acting at different posttranscriptional
levels of the class I MHC presentation pathway.
The data collected so far reveal that the deficient expression of class
I molecules on hepatocytes coincides with another unique feature of
hepatocyte surface that is characteristic of chronic WHV hepatitis
(31, 33, 36). We have previously shown that HPM from
chronically infected woodchucks, independent of the histological
severity of hepatitis and the duration of chronicity, contain large
quantities of WHV envelope proteins irreversibly incorporated into the
membrane lipid bilayer (31, 36). Assessments of the WHs
antigenic content and the binding of exogenous WHsAg to HPM from
different forms of WHV-induced liver pathology revealed that HPM from
animals with CH have the largest amounts of the integrated antigen and
are characterized by an inability to bind exogenous WHsAg
(36), indicating that a massive (saturable) quantity of the
virus envelope material has been inserted. We have hypothesized that
this explicit feature of hepatocyte surface membrane in chronic
disease, which naturally coexists with the abundant amounts of the same
viral proteins in the circulation, may constitute an important element
of protection of infected hepatocytes against immunoelimination and
therefore contributes to prolonged liver disease and virus persistence
(31, 33; reviewed in reference
29). Since the same HPM preparations were analyzed
to determine the expression of class I MHC in this study (study group
1) and WHV envelope polypeptides in our previous work (33),
we can conclusively state that suppression of class I molecules on
hepatocytes occurs only in the context of a massive incorporation of
WHV envelope proteins into HPM. This association, coexisting with heavy
deposits of viral envelope material in the endoplasmic reticulum, which
are typical for hepatocytes in chronically infected livers (33,
36), may exert a severe constraint on intracellular assembly and
transport, as well as on presentation of class I molecules at the
hepatocyte surface. This mechanism provides a reasonable explanation
for the deficiency in class I antigen display on chronically infected
hepatocytes; however, it is rather unlikely that it also operates in
lymphoid cells, which, at best, express WHsAg in minute quantities.
Therefore, it is possible that class I expression in the lymphatic
system is downregulated by WHV through an alternative pathway.
Independent of the mechanism involved, defective expression of class I
MHC complexes on hepatocytes in chronically infected hosts must have
significant immunopathogenic consequences. Among them, as in other
viral infections, the foremost could be evasion of immune surveillance
by virus-specific CTL, leading to suppression of cytolytic and
noncytolytic elimination of virus governed by these cells. This alone
can contribute to the perpetuation of liver disease and facilitates
virus persistence. However, there could also be other implications that
are potentially important for WHV pathogenesis during chronic
infection. Since virally infected cells with reduced class I antigen
expression are considered to be inherently susceptible to attack from
NK cells (4, 27), this may imply that non-class I
MHC-dependent, cell-mediated cytotoxicity might play a role in
controlling virus spread and induction of hepatocellular injury in
chronic hepadnavirus infection. We have recently tested this intriguing
possibility by evaluating perforin and Fas ligand-based cytotoxicity of
circulating lymphoid cells from woodchucks with AH and CH hepatitis
(20). The data from this study showed that the levels of
perforin-dependent killing, which is the principal mechanism of cell
elimination by NK cells (25, 46), are significantly enhanced
in animals with AH but essentially the same in animals with CH and
healthy animals. Although intrahepatic NK cells were not examined in
this study, the above findings suggest that NK cell activity could be
inhibited during the chronic phase of WHV hepatitis, despite suppressed
hepatocyte class I MHC surface expression. In this context, of note are
the past observations postulating that HBV surface antigen (HBsAg) depresses NK cell cytotoxicity, presumably by interfering with their
binding to target cells (1, 8). If this is the case, it is
conceivable that massive quantities of hepadnavirus envelope proteins
inserted into hepatocyte outer membrane, coexisting with the large
amounts of the same antigenic material in serum, may act as a negative
modulator on intrahepatic NK cells during chronic infection. This
mechanism, together with inhibition of hepatocyte surface class I MHC
presentation, might constitute a strategy that the virus employs to
escape elimination by both CTL and NK cells.
At least one more issue requires comment with regard to the findings of
the present study. Identification of severely reduced expression of
class I molecules in splenic lymphoid cells probably reflects a
situation existing in other lymphatic organs in chronic WHV infection,
although we did not see its evidence in circulating lymphoid cells. It
is known that class I molecules are involved in the elaborate network
of interactions between cells of the immune system and that they play
key roles in regulating immune cell functions. Among these, it has been
shown that interruption of the class I MHC presentation on lymphoid
cells is sufficient to induce autoimmune reactions (15),
which are a very common consequence of WHV infection
(9-11). Therefore, downregulation of class I MHC
presentation on lymphoid cells by hepadnavirus infection could
deregulate a variety of host immune reactions whose effects, although
not directly apparent, may profoundly diminish overall effectiveness of
antiviral immune responses. This important issue awaits future studies.
The identified defect in class I MHC presentation on both hepatocyte
and lymphoid cells in chronic infection in this study once again
exemplifies the complexity of the strategies utilized by hepadnavirus
to survive within the host. Unraveling the molecular essence of this
defect and its functional consequences will be necessary to fully
understand the mechanisms underlying the perpetuation of liver disease
and virus persistence in hepadnavirus infections.
 |
ACKNOWLEDGMENTS |
We thank Colleen L. Trelegan for expert assistance and Judy Foote
and Edward Evelly for processing of tissues and histological stainings.
This work was supported by operating grants MT-14818 and RO-15174 to
T.I.M. from the Medical Research Council of Canada. P.D.H. is a
recipient of a Memorial University Fellowship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Molecular
Virology and Hepatology Research, Division of Basic Medical Sciences,
Faculty of Medicine, Health Sciences Centre, Memorial University of
Newfoundland, St. John's, NFLD, Canada A1B 3V6. Phone: (709) 737-7301 (office) or (709) 737-7214 (lab). Fax: (709) 737-2228. E-mail:
timich{at}morgan.ucs.mun.ca.
 |
REFERENCES |
| 1.
|
Azzari, C.,
M. E. Rossi,
M. Resti,
A. L. Caldini,
R. Carbonella,
S. Ciappi, and A. Vierucci.
1992.
VIP restores natural killer cell activity depressed by hepatitis B surface antigen.
Viral Immunol.
5:195-200[Medline].
|
| 2.
|
Barnaba, V.,
A. Franco,
A. Balsano,
C. Alberti,
R. Benvenuto, and F. Balsano.
1989.
Recognition of hepatitis B envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection.
J. Immunol.
143:2650-2655[Abstract].
|
| 3.
|
Brown, T., and K. Mackey.
1997.
Northern hybridization of RNA fractionated by agarose-formaldehyde gel electrophoresis, p. 4.9.2-4.9.8.
In
F. A. Ausebel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
|
| 4.
|
Brutkiewicz, R. R., and R. M. Welsh.
1995.
Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells.
J. Virol.
69:3967-3971[Medline].
|
| 5.
|
Chisari, F. V., and C. Ferrari.
1995.
Hepatitis B virus immunopathogenesis.
Annu. Rev. Immunol.
13:29-60[CrossRef][Medline].
|
| 6.
|
Chu, C.-M.,
W.-C. Shyu,
R.-W. Kuo, and Y.-F. Liaw.
1988.
HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: its role in the pathogenesis of chronic type B hepatitis.
Hepatology
8:712-717[Medline].
|
| 7.
|
Coffin, C. S., and T. I. Michalak.
1999.
Persistence of infectious virus in the offspring of woodchuck mothers recovered from viral hepatitis.
J. Clin. Investig.
104:203-212[Medline].
|
| 8.
|
De Martino, M.,
M. E. Rossi,
A. T. Muccioli,
M. Resti, and A. Vierucci.
1985.
Interference of hepatitis B surface antigen with natural killer cell function.
Clin. Exp. Immunol.
61:90-95[Medline].
|
| 9.
|
Diao, J., and T. I. Michalak.
1997.
Virus-induced anti-asialoglycoprotein receptor autoimmunity in experimental hepadnaviral hepatitis.
Hepatology
25:689-696[CrossRef][Medline].
|
| 10.
|
Diao, J.,
N. D. Churchill, and T. I. Michalak.
1998.
Complement-mediated cytotoxicity and inhibition of ligand binding to hepatocytes by woodchuck hepatitis virus-induced autoantibodies to asialoglycoprotein receptor.
Hepatology
27:1623-1631[CrossRef][Medline].
|
| 11.
|
Dzwonkowski, P., and T. I. Michalak.
1990.
Autoantibody pattern in a woodchuck model of hepatitis B.
Clin. Investig. Med.
13:322-328[Medline].
|
| 12.
|
Ferrari, C.,
A. Penna,
A. Bertoletti,
A. Valli,
A. D. Antoni,
T. Giuberti,
A. Cavali,
M.-A. Petit, and F. Fiaccadori.
1990.
Cellular and immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.
J. Immunol.
145:3442-3449[Abstract].
|
| 13.
|
Früh, K.,
A. Gruhler,
R. Murli Krishna, and G. J. Schoenhals.
1999.
A comparison of viral immune escape strategies targeting the MHC class I assembly pathway.
Immunol. Rev.
168:157-166[CrossRef][Medline].
|
| 14.
|
Früh, K., and Y. Yang.
1999.
Antigen presentation by MHC class I and its regulation by interferon .
Curr. Opin. Immunol.
11:76-81[CrossRef][Medline].
|
| 15.
|
Fu, Y.,
D. M. Nathan,
F. Li,
X. Li, and D. L. Faustman.
1993.
Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
J. Clin. Investig.
91:2301-2307.
|
| 16.
|
Fuqua, S. A.,
S. D. Fitzgerald, and W. L. McGuire.
1990.
A simple polymerase chain reaction method for detection and cloning of low-abundance transcripts.
BioTechniques
9:206-211[Medline].
|
| 17.
|
Guidotti, L. G.,
T. Ishikawa,
M. V. Hobbs,
B. Matzke,
R. Schreiber, and F. V. Chisari.
1996.
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.
Immunity
4:25-36[CrossRef][Medline].
|
| 18.
|
Guidotti, L. G.,
R. Rochford,
J. Chung,
M. Shapiro,
R. Purcell, and F. V. Chisari.
1999.
Viral clearance without destruction of infected cells during acute HBV infection.
Science
284:825-829[Abstract/Free Full Text].
|
| 19.
|
Hill, A., and H. Ploegh.
1995.
Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen.
Proc. Natl. Acad. Sci. USA
92:341-343[Free Full Text].
|
| 20.
|
Hodgson, P. D.,
M. D. Grant, and T. I. Michalak.
1999.
Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis.
Clin. Exp. Immunol.
117:63-70[CrossRef][Medline].
|
| 21.
|
Huang, J.,
J. Kwong,
E. C.-Y. Sun, and T. J. Liang.
1996.
Proteasome complex as a potential cellular target of hepatitis B virus X protein.
J. Virol.
70:5582-5591[Abstract/Free Full Text].
|
| 22.
|
Jin, Y.-M.,
N. D. Churchill, and T. I. Michalak.
1996.
Protease-activated lymphoid cell and hepatocyte recognition site in the preS1 domain of the large woodchuck hepatitis virus envelope protein.
J. Gen. Virol.
77:1837-1846[Abstract/Free Full Text].
|
| 23.
|
Jin, Y.-M.,
I. U. Pardoe,
A. T. H. Burness, and T. I. Michalak.
1994.
Identification and characterization of the cell surface 70-kilodalton sialoglycoprotein(s) as a candidate receptor for encephalomyocarditis virus on human nucleated cells.
J. Virol.
68:7308-7319[Abstract/Free Full Text].
|
| 24.
|
Ju, S.-T.,
D. J. Panka,
H. Cui,
R. Ettinger,
M. El-Khatib,
D. H. Sherr,
B. Z. Stanger, and A. Marshak-Rothstein.
1995.
Fas (CF95)/FasL interactions required for programmed cell death after T-cell activation.
Nature
373:444-448[CrossRef][Medline].
|
| 25.
|
Kagi, D.,
B. Ledermann,
K. Burki,
P. Seiler,
B. Odermatt,
K. J. Olsen,
E. R. Podack,
R. M. Zinkernagel, and H. Hengartner.
1994.
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.
Nature
369:31-37[CrossRef][Medline].
|
| 26.
|
Lau, J. Y. N.,
G. L. Bird,
N. V. Naoumov, and R. Williams.
1993.
Hepatic HLA antigen display in chronic hepatitis B virus infection: relation to hepatic expression of HBV genome/gene products and liver histology.
Dig. Dis. Sci.
38:888-895[CrossRef][Medline].
|
| 27.
|
Ljunggren, H.-G., and K. Karre.
1990.
In search of the `missing self': MHC molecules and NK cell recognition.
Immunol. Today
11:237-244[CrossRef][Medline].
|
| 28.
|
Marche, P. N.,
M. L. Tykocinski,
E. E. Max, and T. J. Kindt.
1985.
Structure of a functional rabbit class I MHC gene: similarity to human class I genes.
Immunogenetics
21:71-82[CrossRef][Medline].
|
| 29.
|
Michalak, T. I.
1998.
The woodchuck animal model of hepatitis B.
Viral Hepatitis Rev.
4:139-165.
|
| 30.
| Michalak, T. I. Occult persistence and
lymphotropism of hepadnaviral infection: insights from the woodchuck
viral hepatitis model. Immunol. Rev., in press.
|
| 31.
|
Michalak, T. I., and N. D. Churchill.
1988.
Interaction of woodchuck hepatitis virus surface antigen with hepatocyte plasma membrane in woodchuck chronic hepatitis.
Hepatology
8:499-506[Medline].
|
| 32.
|
Michalak, T. I.,
N. D. Churchill,
D. Codner,
S. Drover, and W. H. Marshall.
1995.
Identification of woodchuck class I MHC antigens using monoclonal antibodies.
Tissue Antigens
45:333-342[Medline].
|
| 33.
|
Michalak, T. I., and B. Lin.
1994.
Molecular species of hepadnavirus core and envelope polypeptides in hepatocyte plasma membrane of woodchucks with acute and chronic viral hepatitis.
Hepatology
20:275-286[CrossRef][Medline].
|
| 34.
|
Michalak, T. I.,
B. Lin,
N. D. Churchill,
P. Dzwonkowski, and J. R. B. Desousa.
1990.
Hepadna virus nucleocapsid and surface antigens and the antigen-specific antibodies associated with hepatocyte plasma membranes in experimental woodchuck acute hepatitis.
Lab. Investig.
62:680-689[Medline].
|
| 35.
|
Michalak, T. I.,
I. U. Pardoe,
C. S. Coffin,
N. D. Churchill,
D. S. Freake,
P. Smith, and C. L. Trelegan.
1999.
Occult life-long persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis.
Hepatology
29:928-938[CrossRef][Medline].
|
| 36.
|
Michalak, T. I.,
R. L. Snyder, and N. D. Churchill.
1989.
Characterization of the incorporation of woodchuck hepatitis virus surface antigen into hepatocyte plasma membrane in woodchuck hepatitis and in the virus-induced hepatocellular carcinoma.
Hepatology
10:44-55[Medline].
|
| 37.
|
Miller, D. M., and D. D. Sedmak.
1999.
Viral effects on antigen processing.
Curr. Opin. Immunol.
11:94-99[CrossRef][Medline].
|
| 38.
|
Nakamura, I.,
J. T. Nupp,
B. S. Rao,
A. Buckler-White,
R. E. Engle,
J. L. Casey,
J. L. Gerin, and P. J. Cote.
1997.
Cloning and characterization of partial cDNAs for woodchuck cytokines and CD3 epsilon with applications for the detection of RNA expression in tissues by RT-PCR assay.
J. Med. Virol.
53:85-95[CrossRef][Medline].
|
| 39.
|
Nayersina, R.,
P. Fowler,
S. Guilhot,
G. Missale,
A. Cerny,
H.-J. Schlicht,
A. Vitiello,
R. Chesnut,
J. L. Person,
A. G. Redeker, and F. V. Chisari.
1993.
HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
J. Immunol.
150:4659-4671[Abstract].
|
| 40.
|
Oldstone, M. B.
1997.
How viruses escape from cytotoxic T lymphocytes: molecular parameters and players.
Virology
234:179-185[CrossRef][Medline].
|
| 41.
|
Pardoe, I. U., and T. I. Michalak.
1995.
Detection of hepatitis B and woodchuck hepatitis viral DNA in plasma and mononuclear cells from heparinized blood by the polymerase chain reaction.
J. Virol. Methods
51:277-288[CrossRef][Medline].
|
| 42.
|
Penna, A.,
M. Artini,
A. Cavalli,
M. Levero,
A. Bertoletti,
M. Pilli,
F. V. Chisari,
B. Rehermann,
G. Del Prete,
F. Fiaccadori, and C. Ferrari.
1996.
Long-lasting memory T cell responses following self-limited acute hepatitis B.
J. Clin. Investig.
98:1185-1194[Medline].
|
| 43.
|
Pignatelli, M.,
J. Waters,
D. Brown,
A. Lever,
S. Iwarson,
Z. Schaff,
R. Gerety, and H. C. Thomas.
1986.
HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection.
Hepatology
6:349-353[Medline].
|
| 44.
|
Rehermann, B.,
P. Fowler,
J. Sidney,
J. Person,
A. Redeker,
M. Brown,
B. Moss,
A. Sette, and F. V. Chisari.
1995.
The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.
J. Exp. Med.
181:1047-1058[Abstract/Free Full Text].
|
| 45.
|
Rinaldo, C. R., Jr.
1994.
Modulation of major histocompatibility complex antigen expression by viral infection.
Am. J. Pathol.
144:637-650[Medline].
|
| 46.
|
Sayers, T. J.,
A. D. Brooks,
J. K. Lee,
R. G. Fenton,
K. L. Komschlies,
J. M. Wigginton,
R. Winkler-Pickett, and R. H. Wiltrout.
1998.
Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
J. Immunol.
161:3957-3965[Abstract/Free Full Text].
|
| 47.
|
Scharton, T. M., and P. Scott.
1993.
Natural killer cells are a source of interferon- that drives differentiation of CD4+ cell subsets and induces early resistance to Leishmania major in mice.
J. Exp. Med.
178:567-577[Abstract/Free Full Text].
|
| 48.
|
Spies, T.,
M. Bresnahan,
S. Bahram,
D. Arnold,
G. Blanck,
E. Mellins,
D. Pious, and R. DeMars.
1990.
A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway.
Nature
348:744-747[CrossRef][Medline].
|
| 49.
|
Strauss, W.
1997.
Preparation of genomic DNA from mammalian tissue, p. 2.2.1-2.2.3.
In
F. A. Ausebel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
|
| 50.
|
Tennant, B. C., and J. L. Gerin.
1994.
The woodchuck model of hepatitis B virus infection, p. 1455-1466.
In
I. M. Arias, J. L. Boyer, N. Fausto, W. B. Jakoby, D. A. Schachter, and D. A. Shafritz (ed.), The liver: biology and pathobiology. Raven Press, New York, N.Y.
|
| 51.
|
Van Endert, P. M.
1999.
Genes regulating MHC class I processing of antigen.
Curr. Opin. Immunol.
11:82-88[CrossRef][Medline].
|
| 52.
|
Wallach, D.,
M. Fellous, and M. Revel.
1982.
Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.
Nature
299:833-836[CrossRef][Medline].
|
| 53.
|
Zhou, D.-X.,
A. Taraboulos,
J.-H. Ou, and T. S. B. Yen.
1990.
Activation of class I major histocompatibility complex gene expression by hepatitis B virus.
J. Virol.
64:4025-4028[Abstract/Free Full Text].
|
Journal of Virology, May 2000, p. 4483-4494, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dougherty, A. M., Guo, H., Westby, G., Liu, Y., Simsek, E., Guo, J.-T., Mehta, A., Norton, P., Gu, B., Block, T., Cuconati, A.
(2007). A Substituted Tetrahydro-Tetrazolo-Pyrimidine Is a Specific and Novel Inhibitor of Hepatitis B Virus Surface Antigen Secretion. Antimicrob. Agents Chemother.
51: 4427-4437
[Abstract]
[Full Text]
-
Wang, J., Gujar, S. A., Cova, L., Michalak, T. I.
(2007). Bicistronic Woodchuck Hepatitis Virus Core and Gamma Interferon DNA Vaccine Can Protect from Hepatitis but Does Not Elicit Sterilizing Antiviral Immunity. J. Virol.
81: 903-916
[Abstract]
[Full Text]
-
MacParland, S. A., Pham, T. N. Q., Gujar, S. A., Michalak, T. I.
(2006). De novo infection and propagation of wild-type Hepatitis C virus in human T lymphocytes in vitro. J. Gen. Virol.
87: 3577-3586
[Abstract]
[Full Text]
-
Wang, J., Michalak, T. I.
(2006). Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-s2 protein and can be reversed by treatment with gamma interferon.. J. Virol.
80: 8541-8553
[Abstract]
[Full Text]
-
Fiedler, M., Rodicker, F., Salucci, V., Lu, M., Aurisicchio, L., Dahmen, U., Jun, L., Dirsch, O., Putzer, B. M., Palombo, F., Roggendorf, M.
(2004). Helper-Dependent Adenoviral Vector-Mediated Delivery of Woodchuck-Specific Genes for Alpha Interferon (IFN-{alpha}) and IFN-{gamma}: IFN-{alpha} but Not IFN-{gamma} Reduces Woodchuck Hepatitis Virus Replication in Chronic Infection In Vivo. J. Virol.
78: 10111-10121
[Abstract]
[Full Text]
-
Michalak, T. I., Mulrooney, P. M., Coffin, C. S.
(2004). Low Doses of Hepadnavirus Induce Infection of the Lymphatic System That Does Not Engage the Liver. J. Virol.
78: 1730-1738
[Abstract]
[Full Text]
-
Yoo, J.-Y., Desiderio, S.
(2003). Innate and acquired immunity intersect in a global view of the acute-phase response. Proc. Natl. Acad. Sci. USA
100: 1157-1162
[Abstract]
[Full Text]
-
Mulrooney, P. M., Michalak, T. I.
(2002). Quantitative Detection of Hepadnavirus-Infected Lymphoid Cells by In Situ PCR Combined with Flow Cytometry: Implications for the Study of Occult Virus Persistence. J. Virol.
77: 970-979
[Abstract]
[Full Text]
-
Lu, M., Lohrengel, B., Hilken, G., Kemper, T., Roggendorf, M.
(2002). Woodchuck Gamma Interferon Upregulates Major Histocompatibility Complex Class I Transcription but Is Unable To Deplete Woodchuck Hepatitis Virus Replication Intermediates and RNAs in Persistently Infected Woodchuck Primary Hepatocytes. J. Virol.
76: 58-67
[Abstract]
[Full Text]
-
Putzer, B. M., Stiewe, T., Rodicker, F., Schildgen, O., Ruhm, S., Dirsch, O., Fiedler, M., Damen, U., Tennant, B., Scherer, C., Graham, F. L., Roggendorf, M.
(2001). Large Nontransplanted Hepatocellular Carcinoma in Woodchucks: Treatment With Adenovirus-Mediated Delivery of Interleukin 12/B7.1 Genes. JNCI J Natl Cancer Inst
93: 472-479
[Abstract]
[Full Text]
-
Lew, Y.-Y., Michalak, T. I.
(2001). In Vitro and In Vivo Infectivity and Pathogenicity of the Lymphoid Cell-Derived Woodchuck Hepatitis Virus. J. Virol.
75: 1770-1782
[Abstract]
[Full Text]
-
Reignat, S., Webster, G. J.M., Brown, D., Ogg, G. S., King, A., Seneviratne, S. L., Dusheiko, G., Williams, R., Maini, M. K., Bertoletti, A.
(2002). Escaping High Viral Load Exhaustion: CD8 Cells with Altered Tetramer Binding in Chronic Hepatitis B Virus Infection. JEM
195: 1089-1101
[Abstract]
[Full Text]